PROCR and neoplasm: Furthermore, we show that an inhibitory antibody to EPCR expressed by human triple negative breast cancer cells attenuates tumor initiation and growth, indicating that ligands for EPCR present in the tumor microenvironment regulate these cancer stem cell-like populations.